PROFXTECH Q3 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹12.73 Cr
verification pending
Revenue YoY
37.9%
reported change
EBITDA
₹12.51 Cr
latest reported figure
Source
bse pending
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Profxtech Ltd reported 37.9% YoY revenue growth to ₹12.73 crore for 9M FY26, driven by healthy demand across distribution, residential, and corporate segments. However, EBITDA margin compressed 220bps to 9.8% due to 4% impact from rupee depreciation and front-loaded investments in new brand partnerships (Peavey/Crest Audio, Sonodine) and experience centers. PAT grew 16.8% to ₹0.95 crore with net margin at 7.1% versus 8.4% year-ago. Management confirmed price increases of 7-10% effective January 2026 to recover margins, with confidence in achieving full-year 9% PAT margin guidance if Q4 delivers strong double-digit margins. The company added 2 strategic brand partnerships—professional audio (Peavey/Crest Audio) and Indian brand Sonodine—expanding addressable market. Working capital remains elevated with receivables at 79 days versus payables at 57 days. Key risks: achieving 9% annual PAT margin from 7.1% YTD requires significant Q4 outperformance, and rupee volatility remains unhedged.
Colored figures show movement against the previous available record.
Guidance to track
- Management reiterated confidence in maintaining approximately 30% topline growth for full year FY26, supported by new brand partnerships and deeper tier 2/3 penetration.
- Management stated confidence in achieving 9% net profit margin for full FY26, requiring significant double-digit margin in Q4 to bridge from 7.1% YTD. Price increases of 7-10% effective January 2026 are expected to drive margin recovery.
- Two additional experience centers planned (Chennai and Kochi) before fiscal year-end. Mumbai center delayed due to municipal approval bottlenecks but expected to open within FY26.
- Long-term strategic goal to balance B2B (distribution) and B2C (direct retail/institutional) at 50:50 from current ~70:30 split, by focusing on premium HNI residential projects and experience centers.
Risks flagged
- To achieve 9% PAT margin for FY26, Q4 must deliver substantially higher margins than 7.1% YTD. Management admits this requires a 'huge double-digit' margin in the final quarter—a tall order given ongoing rupee volatility and locked-in corporate project pricing.
- Analyst raised concern: receivables at 79 days significantly exceed payables at 57 days. Large corporate clients (Reliance) with negotiated fixed pricing extending to March 31st cannot be repriced. Dealer credit norms (60+ days) remain entrenched despite management's acknowledgment this needs improvement.
- 4% margin erosion attributed to rupee depreciation during Q3. While 7-10% price increases were implemented in January 2026, management admitted further price adjustments may be needed if rupee weakens additional. Ongoing project commitments limit pass-through ability.
- US tariff policies caused manufacturing shifts (China to Vietnam to other countries), disrupting supply for European brands with Chinese manufacturing. Profxtech increased inventory levels as buffer, tying up capital and contributing to margin pressure.
Key quotes
- We have taken a price up quite substantially and despite that substantial increase in price, we have not had any adverse impact in the first month of January in this month so far.
- The impact of the dollar is about 4% of that [margin decline]. And the rest were towards some additional expenses for the preparation of our new businesses going forward.
- Going ahead we remain focused on improving our margins through calibrated pricing actions and operational efficiency. With that we are confident of sustaining healthy momentum in the H2 FY26 and beyond.
Research modules